Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001231615-25-000008
Filing Date
2025-09-02
Accepted
2025-09-02 19:11:34
Documents
1
Period of Report
2025-09-02

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3461
  Complete submission text file 0001231615-25-000008.txt   4758
Mailing Address
Business Address
JEFFS ROGER (Reporting) CIK: 0001231615 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37635 | Film No.: 251287155

Mailing Address ONE WORLD TRADE CENTER, 29TH FLOOR NEW YORK NY 10007
Business Address ONE WORLD TRADE CENTER, 29TH FLOOR NEW YORK NY 10007 (212) 332-3241
Axsome Therapeutics, Inc. (Issuer) CIK: 0001579428 (see all company filings)

EIN.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)